{"id":"W2118615533","doi":"10.1056/nejmoa1110899","title":"Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":545,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Eisai; Sanofi; LEO Pharma; Bayer HealthCare; GlaxoSmithKline; Pfizer; Daiichi Sankyo Europe; Bristol-Myers Squibb","keywords":"Apixaban; Medicine; Intensive care medicine; Venous thromboembolism; Internal medicine; Rivaroxaban; Thrombosis; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009316204,0.0001833135,0.0008727397,0.0003364626,0.00003437261,0.000004446651,0.0001844056,0.0000871165,0.0006458839],"category_scores_gemma":[0.001512302,0.0001192767,0.0001130833,0.0001880562,0.000107945,0.00008952285,0.00003421135,0.0002951619,0.000006912549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009574471,"about_ca_system_score_gemma":0.0001465939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003323039,"about_ca_topic_score_gemma":0.0001455122,"domain_scores_codex":[0.9980848,0.00004718381,0.0007802719,0.0001774645,0.000601934,0.0003082963],"domain_scores_gemma":[0.9983821,0.0001915413,0.0003333714,0.000201058,0.0004809984,0.0004109193],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01193083,0.003248924,0.05821552,0.0003758992,0.0009464468,0.0004907608,0.01383101,0.00000523705,0.0006023839,0.002528918,0.09221288,0.8156112],"study_design_scores_gemma":[0.266566,0.0315698,0.5789042,0.001184684,0.0008572248,0.00008620965,0.0008323392,0.00002984096,0.0004748117,0.002364859,0.1168498,0.0002802486],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9765587,0.000804876,0.00080535,0.005688279,0.002849247,0.0007446632,0.000002988108,0.00001773907,0.01252817],"genre_scores_gemma":[0.9928991,0.0006122267,0.002503994,0.001534467,0.002247845,0.000007419246,0.00001076696,0.00002739824,0.0001568438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8153309,"threshold_uncertainty_score":0.7071975,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05117862459668716,"score_gpt":0.2903365576645683,"score_spread":0.2391579330678811,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}